Navigation Links
Iowa State University conference examines developing bioeconomy
Date:9/18/2007

AMES, Iowa Venture capitalist Vinod Khosla told last years Biobased Industry Outlook Conference at Iowa State University why he believes fuel blends containing 85 percent ethanol can replace the countrys gasoline supply.

Khosla who last year told The New York Times hes invested tens of millions of dollars in private companies developing ethanol production technologies ticked off several reasons: Political and special interest groups back ethanol, theres land to grow new energy crops, ethanols energy balance and emissions are good.

And, he told the conference, The single most important issue for me is how many miles can you drive per acre of land.

Todays technologies produce about 500 gallons of ethanol per acre. In 25 years he said production could jump to about 3,000 gallons per acre.

Whats he saying about ethanol and the bioeconomy these days"

Khosla co-founder of Sun Microsystems and founder of Khosla Ventures in Menlo Park, Calif. will share his views during a keynote address at the 2007 Biobased Industry Outlook Conference, Growing the Bioeconomy, Nov. 5 and 6 at the Iowa State Center on the Iowa State campus. Hes scheduled to speak at 12:30 p.m., Tuesday, Nov. 6 in Hilton Coliseum.

The conference is targeted for elected officials, economic development professionals, manufacturers of biobased products, biofuel producers, farmers, bioprocessing engineers and venture capitalists. Presentations cover plant sciences; feedstock production; conversion of biomass into fuels and products; bioproducts use and energy efficiency; conservation and sustainability; and economics and policy. Early registration for the two-day conference (including a welcome breakfast, two lunches, receptions and materials) is $219 before Oct 1. and $299 after. There is a student rate of $139.

Conference information is at www.bioeconomyconference.org and registration information is at https://www.ucs.iastate.edu/mnet/bio2007/quickregister.html.

Khosla isnt the only big name who will address the conference about the future of the bioeconomy.

J. Craig Venter the scientist who engaged the publicly funded Human Genome Project in a race to map the human genome and who recently announced he had sequenced his own genome will address the conference at 9:15 a.m., Monday, Nov. 5 in Hilton Coliseum.

Venter is founder and president of the non-profit J. Craig Venter Institute and a co-founder of Synthetic Genomics, Inc., in Rockville, Md. The company is using genomics in a variety of ways to design or engineer microbes that can efficiently produce fuels.

Genomics is going to do for the energy and chemical field what it did in the early 1990s for medical biotechnology, Venter told the Washington Post in February.

Also addressing the conference are Jeff Broin, the chief executive officer for the POET biofuel company; Phil Frederickson, the executive vice president of planning, strategy and corporate affairs for the ConocoPhillips energy company; Suzanne Hunt, the bioenergy project manager for the independent Worldwatch Institute that advocates for a sustainable world; and Jeremy Tomkinson, the executive director of the National Non-Food Crops Centre, the United Kingdoms national center for biorenewables.


'/>"/>

Contact: Jill Euken
jeuken@iastate.edu
712-769-2600
Iowa State University
Source:Eurekalert

Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. NC State scientist finds soft tissue in T. rex bones
5. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
6. Test for early detection of prostate cancer shows promise
7. Major new UNC-based drinking water study suggests pregnancy fears may be overstated
8. Disease diagnosis, bioengineering covered at state nano summit
9. U-M researchers identify new blood test for prostate cancer
10. U-M scientists say fused genes trigger the development of prostate cancer
11. K-State professors discover enzyme responsible for creation of a beetles hard shell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
(Date:1/23/2017)...  The latest mobile market research from Acuity Market ... The quarterly average price of a biometric smartphone decreased ... 2016.  There are now 120 sub-$150 models on the ... just 28 a year ago at an average price ... Most , Acuity Market Intelligence Principal, "Biometric Smartphones are ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its unaudited financial results for the third quarter and ... 31, 2016. Third Quarter of Fiscal 2017 ... of fiscal 2017 increased by 18.6% to RMB200.9 million ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
Breaking Biology Technology: